IgE inhibitors (Interprotein)

N/A

Report date: 2025/01/26 18:41:56
NME

Base Information

Drug NameIgE inhibitors (Interprotein)
Drug Alias NameIgE inhibitors (Interprotein)immunoglobulin E inhibitors (Interprotein)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunoglobulin E inhibitors
TargetsImmunoglobulin E
Therapy Area/IndicationsHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInterprotein Corp
China Registration ClassN/A

Develop Information

Active CompaniesInterprotein Corp
Inactive CompaniesN/A
Active IndicationsHypersensitivityAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A